Travere Therapeutics Insider Sold Shares Worth $2,785,021, According to a Recent SEC Filing

MT newswire2026/09/18 07:46

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:46 AM EDT, 09/18/2026 (MT Newswires) -- Jula Inrig, Executive Vice President, Head of Research & Development & Chief Medical Officer, on September 15, 2026, sold 44,674 shares in Travere Therapeutics (TVTX) for $2,785,021. Following the Form 4 filing with the SEC, Inrig has control over a total of 100,491 common shares of the company, with 100,491 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1438533/000190236826000008/xslF345X05/form4-09182026_010947.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Travere Therapeutics Insider Sold Shares Worth $2,785,021, According to a Recent SEC Filing

You may also like

Crypto prices